InvestorsHub Logo
Followers 0
Posts 5407
Boards Moderated 0
Alias Born 06/27/2020

Re: XFundManager post# 101

Tuesday, 02/02/2021 8:21:06 AM

Tuesday, February 02, 2021 8:21:06 AM

Post# of 223
Analyst's $70 Target Price on Regenerative Medicine Biotech More than a Triple

"We believe that PolarityTE can revolutionize the field of regenerative medicine; our target price is $70." – Elemer Piros, Cantor Fitzgerald

https://www.streetwisereports.com/article/2018/02/20/biotech-company-holds-potential-to-revolutionize-the-field-of-regenerative-medicine.html